Bayer Schering Pharma will establish an innovation centre in San Francisco, US, to build a specialty pharmaceutical pipeline and expand its global research network.

The centre will focus on collaborations with academic research scientists and small biotech firms aimed at product development and the commercialisation of drugs.

The centre will also drive a haematology research programme focused on coagulation factors and the discovery of biologic drug candidates.